|
Dr. Chen, 60, co-founded BioCheck in January 1997 and has served since as CEO and COB. Prior to co-founding BioCheck, Dr. Chen co-founded Medix Biotech in 1983, specializing in monoclonal/polyclonal antibodies, enzyme immunoassay test kits and rapid test kits. After Medix Biotech was fully acquired by Genzyme Corporation in 1992, Dr. Chen remained as V.P. of Research and Development until 1995. From 1981 to 1983, Dr. Chen co-founded Pacific Biotech, acquired by Eli Lilly in 1990, where he was instrumental in the development of the first rapid pregnancy test. Dr. Chen holds a BS in Chemistry from Tunghai University in Taiwan and a PhD in Biochemistry from the University of Alberta, Edmonton. Over the years, he has developed more than 50 EIA and rapid tests in different formats, many of which have been approved for marketing by the FDA. Dr. Chen's role is to exploit the Company's findings with respect to possible applications in the diagnostics/prognostic area.
| 